DGAP-News: Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology Seite 1
25.01.2022 - DGAP-News: Evotec SE / Key word(s): Miscellaneous Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology 25.01.2022 / 07:30 The issuer is solely responsible for the content of this announcement. ... Seite 1
Source: wallstreet-online.de